These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16854052)

  • 1. Computational elucidation of the structural basis of ligand binding to the dopamine 3 receptor through docking and homology modeling.
    Hobrath JV; Wang S
    J Med Chem; 2006 Jul; 49(15):4470-6. PubMed ID: 16854052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.
    Varady J; Wu X; Fang X; Min J; Hu Z; Levant B; Wang S
    J Med Chem; 2003 Oct; 46(21):4377-92. PubMed ID: 14521403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational modeling toward understanding agonist binding on dopamine 3.
    Zhao Y; Lu X; Yang CY; Huang Z; Fu W; Hou T; Zhang J
    J Chem Inf Model; 2010 Sep; 50(9):1633-43. PubMed ID: 20695484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key residues involved in the activation and signaling properties of dopamine D3 receptor.
    Kota K; Kuzhikandathil EV; Afrasiabi M; Lacy B; Kontoyianni M; Crider AM; Song D
    Pharmacol Res; 2015 Sep; 99():174-84. PubMed ID: 26116441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational analysis of the structural basis of ligand binding to the crustacean retinoid X receptor.
    Nagaraju GP; Prasad GL; Taliaferro-Smith L; Aruna BV; Naik BR; Sekhar YN
    Comp Biochem Physiol Part D Genomics Proteomics; 2010 Dec; 5(4):317-24. PubMed ID: 20937572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Study and Modified Design of Selective Dopamine D3 Receptor Agonists.
    Duan X; Zhang X; Xu B; Wang F; Lei M
    Chem Biol Drug Des; 2016 Jul; 88(1):142-54. PubMed ID: 26851125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.
    Malmberg A; Nordvall G; Johansson AM; Mohell N; Hacksell U
    Mol Pharmacol; 1994 Aug; 46(2):299-312. PubMed ID: 8078492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of arylpiperazine-reverse amides as biased dopamine D3 receptor ligands.
    Cao Y; Paudel S; Zhang X; Kim KM; Cheon SH
    Bioorg Med Chem; 2015 Sep; 23(17):5264-72. PubMed ID: 26278029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly potent 5-aminotetrahydropyrazolopyridines: enantioselective dopamine D3 receptor binding, functional selectivity, and analysis of receptor-ligand interactions.
    Tschammer N; Elsner J; Goetz A; Ehrlich K; Schuster S; Ruberg M; Kühhorn J; Thompson D; Whistler J; Hübner H; Gmeiner P
    J Med Chem; 2011 Apr; 54(7):2477-91. PubMed ID: 21388142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and evaluation of indolebutylamines as a novel class of selective dopamine D3 receptor ligands.
    Du P; Xu L; Huang J; Yu K; Zhao R; Gao B; Jiang H; Zhao W; Zhen X; Fu W
    Chem Biol Drug Des; 2013 Sep; 82(3):326-35. PubMed ID: 23663349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands.
    Salama I; Hocke C; Utz W; Prante O; Boeckler F; Hübner H; Kuwert T; Gmeiner P
    J Med Chem; 2007 Feb; 50(3):489-500. PubMed ID: 17266201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different binding modes of structurally diverse ligands for human D3DAR.
    Ortore G; Tuccinardi T; Orlandini E; Martinelli A
    J Chem Inf Model; 2010 Dec; 50(12):2162-75. PubMed ID: 21090729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand discovery from a dopamine D3 receptor homology model and crystal structure.
    Carlsson J; Coleman RG; Setola V; Irwin JJ; Fan H; Schlessinger A; Sali A; Roth BL; Shoichet BK
    Nat Chem Biol; 2011 Sep; 7(11):769-78. PubMed ID: 21926995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving selectivity of dopamine D3 receptor ligands.
    Capet M; Calmels T; Levoin N; Danvy D; Berrebi-Bertrand I; Stark H; Schwartz JC; Lecomte JM
    Bioorg Med Chem Lett; 2016 Feb; 26(3):885-888. PubMed ID: 26723530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug design.
    Keck TM; Burzynski C; Shi L; Newman AH
    Adv Pharmacol; 2014; 69():267-300. PubMed ID: 24484980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation.
    Platania CB; Salomone S; Leggio GM; Drago F; Bucolo C
    PLoS One; 2012; 7(9):e44316. PubMed ID: 22970199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of key receptor-ligand interactions of dopaminergic arylpiperazines and the dopamine D2 receptor homology model.
    Sukalovic V; Soskic V; Sencanski M; Andric D; Kostic-Rajacic S
    J Mol Model; 2013 Apr; 19(4):1751-62. PubMed ID: 23300056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of novel hybrid compounds with the D3 dopamine receptor: Site-directed mutagenesis and homology modeling studies.
    Kortagere S; Cheng SY; Antonio T; Zhen J; Reith ME; Dutta AK
    Biochem Pharmacol; 2011 Jan; 81(1):157-63. PubMed ID: 20833147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtype selectivity of dopamine receptor ligands: insights from structure and ligand-based methods.
    Wang Q; Mach RH; Luedtke RR; Reichert DE
    J Chem Inf Model; 2010 Nov; 50(11):1970-85. PubMed ID: 20936866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine transporter comparative molecular modeling and binding site prediction using the LeuT(Aa) leucine transporter as a template.
    Indarte M; Madura JD; Surratt CK
    Proteins; 2008 Feb; 70(3):1033-46. PubMed ID: 17847094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.